Skip to main content
OpenTrials
Completed

NCT Number: NCT03881722

Effect of Magnesium Alginate in Infants With Gastroesophageal Reflux.

Recurrent regurgitation stress the infants and their parents and often results in an inappropirate use of PPI prescription in infancy. The aim of this study is to evaluate the efficacy of Mg alginate in infants with symptoms of gastroesophageal reflux.

Completed

Looking for future studies?

Notify Me

Key information

Age range

3 week–1 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Dept Of Obstetrics and Neonatology - Section of Neonatology University of Bari Policlinico Hospital

Bari, 70124, Italy

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • symptoms suggestive of GER, evaluated through a validated questionnaire (Infant Gastroesophageal Reflux Questionnaire Revised: I-GERQ-R > 16)
  • informed consent signed

Exclusion criteria

  • congenital or chronic diseases
  • use of anti acid drugs

Treatment and study plan

Mg alginate

Dietary Supplement

Mg alginate after feedings

Primary outcomes

  1. Infant Gastro-Esophageal Reflux Questionnaire Revised

    Time frame: through study completion, an average of 1 month

    12-item validated questionnaire called Infant Gastro-Esophageal Reflux Questionnaire Revised (I-GERQ-R) which include different questions about regurgitation, crying, feeding and respiratory problems

Sponsors and collaborators

Lead sponsor

Policlinico Hospital

Other

Registry information

Important dates

Study start
2016
Primary completion
2018
Study completion
2018
First posted
Mar 19, 2019
Registry last updated
Mar 19, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.